Jonathan C. Fox, Director at Edgewise Therapeutics, Inc. (EWTX), bought 21,714 shares at $9.30 ($202K) on 2023-12-26, disclosed to the SEC on 2023-12-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.30 | 10,857 | $101K | 50.0% |
| 2 | $9.30 | 10,857 | $101K | 50.0% |
| Total | $9.30 avg | 21,714 | $202K | 100% |
| Filing → |
| EIDX | SELL | 2020-09-16 | $369K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |
| EIDX | SELL | 2020-06-05 | $250K | — | Filing → |